✦ LIBER ✦

Is the use of albumin of value in cirrhosis?: The case not so in favour, or is there an alternative?

✍ Scribed by A.K Burroughs

Book ID: 119631629
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 64 KB
Volume: 35
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(03)00386-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is the use of albumin of value in the tr

Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour

✍ G Laffi; P Gentilini; R.G Romanelli; G La Villa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Is there any value in using cyclosporine

Is there any value in using cyclosporine in the treatment of Crohn's disease—to use or not to use?

✍ Peter A. Banks; Daniel H. Present 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

Evidence that the loss of rat liver cyto

Evidence that the loss of rat liver cytochrome P450 in vitro is not solely associated with the use of collagenase, the loss of cell-cell contacts and/or the absence of an extracellular matrix

✍ Matthew C. Wright; Alan J. Paine 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 835 KB

Is there value in using physician billin

Is there value in using physician billing claims along with other administrative health care data to document the burden of adolescent injury? An exploratory investigation with comparison to self-reports in Ontario, Canada

✍ Beth K Potter; Douglas Manuel; Kathy N Speechley; Iris A Gutmanis; M Karen Campb 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 273 KB

Incident acute coronary syndromes in chr

Incident acute coronary syndromes in chronic dialysis patients in the United States11The opinions are solely those of the authors and do not represent an endorsement by the Department of Defense or the National Institutes of Health. This is a U.S. Government work. There are no restrictions on its use.

✍ Trespalacios, Fernando C.; Taylor, Allen J.; Agodoa, Lawrence Y.; Abbott, Kevin 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 76 KB

## Background: Patients on dialysis have a disproportionately high rate of cardiovascular disease (cvd). however, the incidence and risk factors for incident acute coronary syndromes (acs) have not been previously assessed in dialysis patients. ## Methods: We analyzed the united states renal data

Development of an immunobiosensor assay

Development of an immunobiosensor assay for the beta-adrenergic compound zilpaterol* * The use of trade, firm, or corporation names in this publication is for the information and convenience of the reader. Such use does not constitute an official endorsement or approval by the United States Department of Agriculture or the Agricultural Research Service of any product or service to the exclusion of others that may be suitable.

✍ Shelver‡, Weilin L.; Keum, Young-Soon; Li, Qing X.; Fodey, Terence L.; Elliott, 📂 Article 📅 2005 🏛 Taylor and Francis Group 🌐 English ⚖ 163 KB